Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of mTOR inhibition on metabolism and physical exercise performance in renal transplant patients
2009-010541-31Phase 4Active
- Sponsor
- Nephrology Service of Bellvitge University Hospital
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of everolimus in Kidney allograft status (RTx), sponsored by Nephrology Service of Bellvitge University Hospital. Primary endpoint: Anthropometric analysis. Started May 2010; status: active.
02
Drugs
everolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2009-010541-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010541-31.